文献速递心力衰竭与心肌病血脂与心血管预防

心血管危险因素与生物标志物和新发心衰的性别特异性关联

Sex-Specific Associations of Cardiovascular Risk Factors and Biomarkers With Incident Heart Failure.
PubMed 文献 · J Am Coll Cardiol · 2020-01-01

该研究基于4个社区队列、随访12.5年、22,756名基线无心衰参与者,评估心血管危险因素和生物标志物与新发心衰的性别特异性关联。结果显示多数危险因素和生物标志物在两性中关联强度相似,临床模型区分度男性C统计量0.80、女性0.83,加入利钠肽或肌钙蛋白后改善有限。

要点

  • 多数心血管危险因素在两性中与新发心衰强且相似关联,支持同等重视危险因素控制。
  • 临床模型区分度男性C统计量0.80、女性0.83,表现良好。
  • 加入利钠肽(男性)或肌钙蛋白(女性)后模型改善幅度有限。

核心结论

  • 心血管危险因素在两性中与新发心衰强且相似关联,强调社区中危险因素控制对降低心衰风险同等重要。
  • 单个生物标志物的预测价值存在细微性别差异,但加入临床心衰风险预测模型后总体改善有限。

研究设计与样本

  • 基于4个社区队列的分析,随访12.5年,参与者于1989至2002年间招募,基线无心衰。
  • 共纳入22,756名参与者,平均年龄60±13岁,女性占53%。

主要发现

  • 随访期间2,095名参与者发生心衰,其中女性占47%。
  • 年龄、吸烟、2型糖尿病、高血压、体重指数、房颤、心肌梗死、左心室肥厚和左束支传导阻滞在两性中均与心衰强关联(p<0.001)。
  • 临床模型区分度男性C统计量=0.80,女性C统计量=0.83。
  • 多数生物标志物在两性中与心衰强且相似关联。
  • 男性加入利钠肽后ΔC统计量=0.006(似然比卡方=146,p<0.001);女性加入心肌肌钙蛋白后ΔC统计量=0.003(似然比卡方=73,p<0.001)。

临床怎么用

  • 在社区心衰风险评估中,应同等重视男女两性的心血管危险因素控制。
  • 临床心衰风险预测模型加入利钠肽或心肌肌钙蛋白的增量价值有限,需权衡检测成本与获益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Whether cardiovascular (CV) disease risk factors and biomarkers associate differentially with heart failure (HF) risk in men and women is unclear. OBJECTIVES: The purpose of this study was to evaluate sex-specific associations of CV risk factors and biomarkers with incident HF. METHODS: The analysis was performed using data from 4 community-based cohorts with 12.5 years of follow-up. Participants (recruited between 1989 and 2002) were free of HF at baseline. Biomarker measurements included natriuretic peptides, cardiac troponins, plasminogen activator inhibitor-1, D-dimer, fibrinogen, C-reactive protein, sST2, galectin-3, cystatin-C, and urinary albumin-to-creatinine ratio. RESULTS: Among 22,756 participants (mean age 60 ± 13 years, 53% women), HF occurred in 2,095 participants (47% women). Age, smoking, type 2 diabetes mellitus, hypertension, body mass index, atrial fibrillation, myocardial infarction, left ventricular hypertrophy, and left bundle branch block were strongly associated with HF in both sexes (p < 0.001), and the combined clinical model had good discrimination in men (C-statistic = 0.80) and in women (C-statistic = 0.83). The majority of biomarkers were strongly and similarly associated with HF in both sexes. The clinical model improved modestly after adding natriuretic peptides in men (ΔC-statistic = 0.006; likelihood ratio chi-square = 146; p < 0.001), and after adding cardiac troponins in women (ΔC-statistic = 0.003; likelihood ratio chi-square = 73; p < 0.001). CONCLUSIONS: CV risk factors are strongly and similarly associated with incident HF in both sexes, highlighting the similar importance of risk factor control in reducing HF risk in the community. There are subtle sex-related differences in the predictive value of individual biomarkers, but the overall improvement in HF risk estimation when included in a clinical HF risk prediction model is limited in both sexes.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Suthahar N, Lau ES, Blaha MJ, et al. Sex-Specific Associations of Cardiovascular Risk Factors and Biomarkers With Incident Heart Failure. J Am Coll Cardiol. 2020. PMID: 32943164. doi:10.1016/j.jacc.2020.07.044

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。